<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>13</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Tim Reyns</style></author><author><style face="normal" font="default" size="100%">Vanessa Mathys</style></author><author><style face="normal" font="default" size="100%">Groenen,G.</style></author><author><style face="normal" font="default" size="100%">Mirjana Andjelkovic</style></author><author><style face="normal" font="default" size="100%">Joris Van Loco</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Simultaneous determination of anti-tuberculosis drug levels in human plasma by ultra-performance liquid chromatography-tandem mass spectrometry for subsequent Therapeutic Drug Monitoring</style></title><secondary-title><style face="normal" font="default" size="100%">Alternative Sampliong Strategies in Toxicology and Therapeutic Drug Monitoring - IATDMCT Satellite Meeting 2014</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">alternative</style></keyword><keyword><style  face="normal" font="default" size="100%">Anti tubercolosis drugs</style></keyword><keyword><style  face="normal" font="default" size="100%">DRUG</style></keyword><keyword><style  face="normal" font="default" size="100%">Drug Monitoring</style></keyword><keyword><style  face="normal" font="default" size="100%">Human</style></keyword><keyword><style  face="normal" font="default" size="100%">LC-MS/MS</style></keyword><keyword><style  face="normal" font="default" size="100%">LEVEL</style></keyword><keyword><style  face="normal" font="default" size="100%">levels</style></keyword><keyword><style  face="normal" font="default" size="100%">Liquid chromatography-tandem mass spectrometry</style></keyword><keyword><style  face="normal" font="default" size="100%">Mass</style></keyword><keyword><style  face="normal" font="default" size="100%">Mass Spectrometry</style></keyword><keyword><style  face="normal" font="default" size="100%">meeting</style></keyword><keyword><style  face="normal" font="default" size="100%">Monitoring</style></keyword><keyword><style  face="normal" font="default" size="100%">plasma</style></keyword><keyword><style  face="normal" font="default" size="100%">Strategies</style></keyword><keyword><style  face="normal" font="default" size="100%">Strategy</style></keyword><keyword><style  face="normal" font="default" size="100%">TDM</style></keyword><keyword><style  face="normal" font="default" size="100%">Therapeutic drug monitoring</style></keyword><keyword><style  face="normal" font="default" size="100%">Toxicology</style></keyword><keyword><style  face="normal" font="default" size="100%">ultra-performance liquid chromatography-tandem mass spectrometry</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2014</style></year><pub-dates><date><style  face="normal" font="default" size="100%">18/9/2014</style></date></pub-dates></dates><publisher><style face="normal" font="default" size="100%">NA</style></publisher><pub-location><style face="normal" font="default" size="100%">NA</style></pub-location><language><style face="normal" font="default" size="100%">eng</style></language><issue><style face="normal" font="default" size="100%">IATDMCT</style></issue><custom1><style face="normal" font="default" size="100%">2270</style></custom1><custom2><style face="normal" font="default" size="100%">18/09/2014 - 19/09/2014</style></custom2></record></records></xml>